Author

V. Volk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Mundt· 1 shared B. Papke· 1 shared F. Feuerhake· 1 shared F. Kuehnel· 1 shared F. Wegwitz· 1 shared K. L. Schneider· 1 shared L.-C. Conradi· 1 shared R. Schulz-Heddergott· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Mundt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition

T. Isermann, K. L. Schneider, F. Wegwitz, T. De Oliveira, L.-C. Conradi, V. Volk, F. Feuerhake, B. Papke, S. Stintzing, B. Mundt, F. Kuehnel, U. M. Moll, R. Schulz-Heddergott

This study shows that combining HSP90 inhibitors with p53 activation or CDK4/6 inhibition enhances colorectal cancer therapy by disrupting the HSF1-HSR feedback loop.

bioRxiv · Feb 22, 2024Cancer Biology